– UK, Glasgow – DeepMatter Group PLC (LON: DMTR), the company focusing on digitizing chemistry, today announced the appointment of Bryn Roberts to its Board as Non-Executive Director with effect from 1 August 2021.
“I am delighted to welcome Bryn to DeepMatter. To have such a credible industry expert on the Board is a great vote of confidence in our team and we look forward to tapping into his wealth of insight and expertise to drive our offerings forward. An inspiring leader in the world of informatics, who is pushing the field in novel data-driven healthcare approaches, Bryn is a perfect fit for DeepMatter where we enable scientists to use data to discover and develop medicines that transform patients’ lives, reliably and cost effectively. His expertise will be invaluable as we continue in our goal of integrating chemistry with technology by building and commercialising powerful data platforms.” said Non-Executive Chair, Karen Bach.
About Bryn Roberts
Bryn Roberts brings a wealth of experience in the pharmaceutical sector having spent 15 years at Roche, the Swiss multinational healthcare company. He is currently SVP and Head of Data Services at Roche Information Solutions and until recently was Global Head of Operations, Pharmaceutical Research & Early Development. As a member of the Pharmaceutical Research & Early Development Leadership Team, he led innovation in disciplines such as Data Science and Laboratory Automation, including diverse applications of Digital and Artificial Intelligence technologies.
Bryn Roberts has a deep understanding of informatics and innovation in the laboratory, having overseen the development and operation of Roche’s R&D Innovation Centres, including new state-of-the-art laboratories in Basel, Zurich, Munich, and Shanghai. DeepMatter will seek to leverage his knowledge to further develop its powerful data platforms and ensure they meet the needs of the world’s pharmaceutical industry, supporting the increased reproducibility, predictability, and sustainability of chemistry.
Bryn Roberts is a Fellow at the University of Oxford, an Associated Faculty member with the University of Frankfurt Big Data Lab, lectures in medical informatics at the University of Applied Sciences, Switzerland and sits on several prestigious advisory boards.
Bryn has previously been recognized in the Fierce Biotech IT list of Top 10 Biotech Techies and the Top 50 Big Data Influencers in Precision Medicine by the Big Data Leaders Forum.
Bryn Roberts said: “My career goal is to drive and enable the delivery of innovative healthcare solutions that address a significant unmet need. The value of data captured directly in the lab via DeepMatter and the insights the industry can extract from them will spur further innovation. I am excited to be joining DeepMatter as my first commercial Non-executive position and look forward to helping them on their journey to accelerate scientific computing in the pharma industry.”
About DeepMatter Group plc
DeepMatter is building and commercializing the most powerful data platforms, to enable scientists to easily perform and optimize chemical reactions, by increasingly integrating chemistry with technology. Ultimately this will allow the greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesized through robotics.
For more information: https://www.deepmatter.io/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
